BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22267799)

  • 1. Cancer. Taking a back door to target Myc.
    Evan G
    Science; 2012 Jan; 335(6066):293-4. PubMed ID: 22267799
    [No Abstract]   [Full Text] [Related]  

  • 2. A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.
    Kessler JD; Kahle KT; Sun T; Meerbrey KL; Schlabach MR; Schmitt EM; Skinner SO; Xu Q; Li MZ; Hartman ZC; Rao M; Yu P; Dominguez-Vidana R; Liang AC; Solimini NL; Bernardi RJ; Yu B; Hsu T; Golding I; Luo J; Osborne CK; Creighton CJ; Hilsenbeck SG; Schiff R; Shaw CA; Elledge SJ; Westbrook TF
    Science; 2012 Jan; 335(6066):348-53. PubMed ID: 22157079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
    Barsyte-Lovejoy D; Lau SK; Boutros PC; Khosravi F; Jurisica I; Andrulis IL; Tsao MS; Penn LZ
    Cancer Res; 2006 May; 66(10):5330-7. PubMed ID: 16707459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Of mice and Myc: c-Myc and mammary tumorigenesis.
    Jamerson MH; Johnson MD; Dickson RB
    J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):27-37. PubMed ID: 15082916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc.
    Salghetti SE; Kim SY; Tansey WP
    EMBO J; 1999 Feb; 18(3):717-26. PubMed ID: 9927431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC in oncogenesis and as a target for cancer therapies.
    Albihn A; Johnsen JI; Henriksson MA
    Adv Cancer Res; 2010; 107():163-224. PubMed ID: 20399964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene regulation: fine-tuned amplification in cells.
    Dang CV
    Nature; 2014 Jul; 511(7510):417-8. PubMed ID: 25043013
    [No Abstract]   [Full Text] [Related]  

  • 8. Involvement of Myc targets in c-myc and N-myc induced human tumors.
    Ben-Yosef T; Yanuka O; Halle D; Benvenisty N
    Oncogene; 1998 Jul; 17(2):165-71. PubMed ID: 9674700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlocking the mysterious mechanisms of Myc.
    Nat Med; 2013 Jan; 19(1):26-7. PubMed ID: 23296005
    [No Abstract]   [Full Text] [Related]  

  • 10. Transcriptional regulation and transformation by Myc proteins.
    Adhikary S; Eilers M
    Nat Rev Mol Cell Biol; 2005 Aug; 6(8):635-45. PubMed ID: 16064138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
    Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
    Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights.
    Facchini LM; Penn LZ
    FASEB J; 1998 Jun; 12(9):633-51. PubMed ID: 9619443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdc25 cell-cycle phosphatase as a target of c-myc.
    Galaktionov K; Chen X; Beach D
    Nature; 1996 Aug; 382(6591):511-7. PubMed ID: 8700224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of c-myc proto-oncogene in primary human breast carcinomas.
    Pavelic ZP; Steele P; Preisler HD
    Anticancer Res; 1991; 11(4):1421-7. PubMed ID: 1660688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
    Cosgrave N; Hill AD; Young LS
    J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Myc in breast cancer.
    Liao DJ; Dickson RB
    Endocr Relat Cancer; 2000 Sep; 7(3):143-64. PubMed ID: 11021963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases.
    Sipos F; Firneisz G; Műzes G
    World J Gastroenterol; 2016 Sep; 22(35):7938-50. PubMed ID: 27672289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.
    Lee YC; Chang WW; Chen YY; Tsai YH; Chou YH; Tseng HC; Chen HL; Wu CC; Chang-Chien J; Lee HT; Yang HF; Wang BY
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
    Dadiani M; Seger D; Kreizman T; Badikhi D; Margalit R; Eilam R; Degani H
    Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tipping the balance: Cdk2 enables Myc to suppress senescence.
    Hydbring P; Larsson LG
    Cancer Res; 2010 Sep; 70(17):6687-91. PubMed ID: 20713526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.